ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
04/27/201522:05:08Mylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update
04/27/201517:11:34Filing of Certain Prospectuses and Communications in Connection...
04/27/201515:26:36Mylan Rejects Teva's Unsolicited $40 Billion Bid--3rd Update
04/27/201513:41:25Mylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update
04/27/201512:21:00Mylan Schedules First Quarter 2015 Financial Results Conference...
04/27/201511:34:51Mylan Rejects Teva's Unsolicited $40 Billion Bid
04/27/201511:00:13Mylan Rejects Teva's Unsolicited $40 Billion Bid
04/27/201510:50:24Mylan Rejects Teva's Unsolicited $40 Billion Bid
04/27/201509:19:00Mylan Board Unanimously Rejects Unsolicited Expression of Interest...
04/24/201515:59:35Mylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
04/24/201513:04:32Mylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
04/24/201512:16:36Mylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
04/24/201512:09:00Perrigo Rejects Mylan Unsolicited Offer
04/24/201511:21:57Mylan to Make Formal Bid for Perrigo -- 3rd Update
04/24/201511:11:04Mylan to Make Formal Bid for Perrigo -- 2nd Update
04/24/201510:51:52Mylan to Make Formal Bid for Perrigo -- Update
04/24/201510:50:09Mylan to Make Formal Bid for Perrigo
04/24/201510:36:24Mylan to Make Formal Bid for Perrigo
04/24/201509:44:00Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In...
04/24/201509:30:52Mylan NV PT Raised to $82.00 at Deutsche Bank (MYL)

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad